Safety and efficacy of Cabozantinib for metastatic renal cell carcinoma (mRCC): real world data from an Italian Expanded Access Program (EAP)
2018 ◽
Vol 16
(4)
◽
pp. e945-e951
◽
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):